NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Receivables

NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s receivables stands at $33K as of December 2025. That compares with $160K in the prior-year period — down 79.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) reported $33K in receivables versus $160K a year earlier — a 79.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $160K in the prior-year period — down 79.9% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s receivables evolved across reporting periods, while the comparison chart places NRSNW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.